Akebia Therapeutics, Inc. (AKBA)
1.345
-0.02
(-1.10%)
USD |
NASDAQ |
Jan 20, 16:00
1.33
-0.02
(-1.12%)
After-Hours: 17:17
Akebia Therapeutics EPS Diluted (Quarterly): 0.002 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Pfizer Inc. | 0.6197 |
| Theravance Biopharma, Inc. | 0.0696 |
| Zevra Therapeutics, Inc. | -0.0097 |
| Organon & Co. | 0.6138 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.54M |
| Revenue (Quarterly) | 58.77M |
| Total Expenses (Quarterly) | 58.23M |
| Enterprise Value | 406.05M |
| Gross Profit Margin (Quarterly) | 83.49% |
| Profit Margin (Quarterly) | 0.92% |
| Earnings Yield | -5.66% |
| Operating Earnings Yield | 5.25% |
| Normalized Earnings Yield | -4.238 |